Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 1 of the 13 calendar months from Oct 2025 to Oct 2026: Aug 2026.
- Largest single sale: $2.1M (18,208 shares) of Rhythm Pharmaceuticals, Inc. on Aug 12, 2026. Filing
- Last sale before this period: Apr 29, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Rhythm Pharmaceuticals, Inc. (RYTM) | EVP, Head of International | Oct 6, 2020 | Aug 14, 2026 |
Recent filings
The last 4 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Aug 12, 2026, Rhythm Pharmaceuticals, Inc.: sold 57,000 shares for $6.6M, under a disclosed plan; 46,625 shares acquired by exercising options. 1 filing: 1
- Apr 1, 2026, Rhythm Pharmaceuticals, Inc.: 12,875 shares vested. 1 filing: 1
- Feb 14, 2026, Rhythm Pharmaceuticals, Inc.: 10,000 shares vested. 1 filing: 1
- Feb 1, 2026, Rhythm Pharmaceuticals, Inc.: 5,500 shares vested. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.